Radiographic progression free survival: A new biomarker of response to treatment?

Date

07 Oct 2016

Session

Imaging in metastatic prostate cancer

Presenters

Michael Morris

Authors

M.J. Morris

Author affiliations

  • Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, 10065 - New York/US
More

Resources

Resources from the same session

The role of PET/CT

Presenter: Uwe Haberkorn

Session: Imaging in metastatic prostate cancer

Resources:

Presentation

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings